At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 319 enrolled
Drug / intervention
Escitalopram +2 moredrug
Likely dose
Escitalopram 10 mg daily for 6 weeks, then 20 mg daily for 16 weeksAI-extracted
Key inclusion· 6
- ✓Unipolar major depression diagnosis
- ✓HRSD (17-item) score ≥15
- ✓English-speaking
- ✓Willing to discontinue other psychotropic medications
Key exclusion· 6
- ✕Lifetime bipolar disorder, schizophrenia, schizoaffective disorder, or psychotic disorder
- ✕MMSE score ≤17
- ✕Current or recent suicidal ideation/intent
- ✕History of non-adherence in other Center protocols
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Geriatric Depression: Getting Better, Getting Well
In Brief
A Phase 4 clinical trial evaluating Escitalopram, Interpersonal Psychotherapy, and 1 other intervention for Depression. Completed, enrolled 319 participants across 1 site.
Detailed Summary
This study will determine whether adding interpersonal psychotherapy to treatment with the antidepressant escitalopram will be more effective in reducing symptoms of depression than antidepressant medication alone.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDepression
CountriesUnited States
CollaboratorsNational Institute of Mental Health (NIMH)
Timeline
Phase 4CompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartApr 2004
First PostedSep 2005
Primary CompletionAug 2009
TodayJul 2026
First PostedSep 15, 2005
Enrollment StartApr 1, 2004
Primary CompletionAug 1, 2009
TodayJul 2, 2026
Enrollment to primary: 5.3 yearsPosted 20.8 years ago
Interventions
Escitalopramdrug
Escitalopram 10 mg daily for first 6 weeks, followed by escitalopram 20 mg daily for 16 additional weeks.
Interpersonal Psychotherapybehavioral
16 sessions of interpersonal psychotherapy (IPT)
Clinical Monitoringbehavioral
16 weeks of depression care management(DCM). No psychotherapy will be provided.